RIMES Technologies, the leading integrator of financial data for the investment community, has won the 2008 Best Data Provider to the Buy Side Award. RIMES had previously won the same award in 2007.
Hosted by Buy-Side Technology magazine, these awards recognise products and services in the buy-side technology vendor industry and are open to any technology company operating in this space globally. The aim of the awards is to acknowledge the leading technologies and vendors in their areas of expertise through an auditable and transparent methodology underpinned by the input and experience of four buy-side-focused technology consultants: Investit, Morse, Deloitte Consulting, and The Aite Group.
Victor Anderson, Editor of Buy-Side Technology, commented: “It’s pleasing to see a medium-size firm win such a high-profile category for the second year in succession. This illustrates that the methodology we use doesn’t favour big firms at the expense of smaller vendors – instead, it seeks to acknowledge outstanding service, innovation, and the ability to specifically address the needs of the buy side, which RIMES Technologies has clearly achieved.”
Christian Fauvelais, Chief Executive Officer and Co-President of RIMES Technologies commented: “Once again, we are extremely honoured to be receiving this Award from Buy-Side Technology. Following the successful launch of RIMES SmartFiles® for Performance Attribution in 2007, this year we launched SmartFiles® for Fixed Income Attribution. Both services bring multiple sources of financial data together on a single platform. This Award reinforces our pledge to provide outstanding data services to fund managers, investment banks, custodians and corporates worldwide, empowering them to improve their productivity and performance.”
- Full-Service Model: The Single-Platform Utopia That Can Leave You Wanting More
- Tap Managed Services to Solve and Scale for the ETF Data Challenge
- The FCA Highlights Importance of Robust Insider List Management
- ETFs and Transparency: Four Questions Institutional Investors Should Ask
- EU BMR: Sell-side in the crosshairs